Lectin-mediated mucosal delivery of drugs and microparticles

Advanced Drug Delivery Reviews

Volumn 43, Issue 2-3, 2000, Pages 207-223

  Clark, M Ann ^a   Hirst, Barry H ^a   Jepson, Mark A ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Bioadhesins; Fimbriae; Invasin; Lectins; M cells; Microbial adhesins; Microparticles; Mucosal vaccines; Peyer's patches; Targeting

Indexed keywords

BIOASSAY; GASTROENTEROLOGY; VACCINES;

LECTINS; MICROPARTICLES; MUCCUSAL VACCINES;

DRUG THERAPY;

ADHESIN; CARBOHYDRATE; DRUG CARRIER; IMMUNOGLOBULIN; LECTIN;

DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG TARGETING; EYE; GASTROINTESTINAL MUCOSA; HUMAN; INTESTINE CELL; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; VACCINE PRODUCTION;

EID: 0034734982     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00070-3     Document Type: Article

References (123)

1. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine. 12:1994;387-400.
2. Sharon N. Lectin-carbohydrate complexes of plants and animals: an atomic view. Trends Biochem. Sci. 18:1993;221-226.
3. Frey A., Neutra M.R. Targeting of mucosal vaccines to Peyer's patch M cells. Behring Inst. Mitt. 98:1997;376-389.
4. DiBiase M.D., Morrel E.M. Oral delivery of microencapsulated proteins. Pharm. Biotechnol. 10:1997;255-288.
5. Hillery A.M. Microparticulate delivery systems: potential drug/vaccine carriers via mucosal routes. Pharm. Sci. Technol. Today. 1:1998;69-75.
6. Brayden D.J., O'Mahony D.J. Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines. Pharm. Sci. Technol. Today. 1:1998;291-299.
7. Wilding I.R., Davis S.S., O'Hagan D.T. Targeting of drugs and vaccines to the gut. Pharm. Ther. 62:1994;97-124.
8. Lehr C.-M. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit. Rev. Ther. Drug Carrier Syst. 11:1994;119-160.
9. Lehr C.-M., Poelma F.G.J., Junginger H.E., Tukker J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:1991;235-240.
10. Jepson M.A., Clark M.A. Studying M cells and their role in infection. Trends Microbiol. 6:1998;359-365.
11. Gebert A., Rothkötter H.-J., Pabst R. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:1996;91-159.
12. Neutra M.R., Mantis N.J., Frey A., Giannasca P.J. The composition and function of M cell apical membranes: implications for microbial pathogenesis. Semin. Immunol. 11:1999;171-181.
13. Sansonetti P.J., Phalipon A. M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin. Immunol. 11:1999;193-203.
14. Gebert A., Pabst R. M cells at locations outside the gut. Semin. Immunol. 11:1999;165-170.
15. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-266.
16. McClean S., Prosser E., Meehan E., O'Malley D., Clarke N., Ramtoola Z., Brayden D. Binding and uptake of biodegradable poly-DL-lactide micro- and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6:1998;153-163.
17. Bland P.W., Warren L.G. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology. 58:1986;1-7.
18. Bland P.W., Warren L.G. Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells. Immunology. 58:1986;9-14.
19. Strobel S., Mowat A.M. Immune responses to dietary antigens: oral tolerance. Immunol. Today. 19:1998;173-181.
20. Frey A., Giannasca K.T., Weltzin R., Giannasca P.J., Reggio H., Lencer W.I., Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: Implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:1996;1045-1059.
21. Jepson M.A., Clark M.A., Foster N., Mason C.M., Bennett M.K., Simmons N.L., Hirst B.H. Targeting to intestinal M cells. J. Anat. 189:1996;507-516.
22. O'Hagan D.T. The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat. 189:1996;477-482.
23. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: histological and analytical evidence. J. Drug Target. 3:1995;65-70.
24. Jepson M.A., Simmons N.L., Savidge T.C., James P.S., Hirst B.H. Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells. Cell Tissue Res. 271:1993;399-405.
25. Jepson M.A., Simmons N.L., O'Hagan D.T., Hirst B.H. Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells. J. Drug Target. 1:1993;245-249.
26. Jani P., Halbert G.W., Langridge J., Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
27. Jani P., Halbert G.W., Langridge J., Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42:1990;821-826.
28. Eldridge J.H., Meulbroek J.A., Staas J.K., Tice T.R., Gilley R.M. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:1989;191-202.
29. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Release. 11:1990;205-214.
30. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: Effect of particle size. Pharm. Res. 13:1996;1838-1845.
31. Jepson M.A., Mason C.M., Simmons N.L., Hirst B.H. Enterocytes in the follicle-associated epithelia of rabbit small intestine display distinctive lectin-binding properties. Histochemistry. 103:1995;131-134.
32. Sharma R., van Damme E.J.M., Peumans W.J., Sarsfield P., Schumacher U. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. 105:1996;459-465.
33. Jepson M.A., Mason C.M., Clark M.A., Simmons N.L., Hirst B.H. Variations in lectin binding properties of intestinal M cells. J. Drug Target. 3:1995;75-77.
34. Clark M.A., Jepson M.A., Simmons N.L., Booth T.A., Hirst B.H. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. 41:1993;1679-1687.
35. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res. 282:1995;455-461.
36. Giannasca P.J., Giannasca K.T., Falk P., Gordon J.I., Neutra M.R. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. 267:1994;G1108-G1121.
37. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Differential surface characteristics of M cells from mouse intestinal Peyer's and caecal patches. Histochem. J. 26:1994;271-280.
38. Gebert A., Posselt W. Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells. J. Histochem. Cytochem. 45:1997;1341-1350.
39. Lelouard H., Reggio H., Mangeat P., Neutra M., Montcourrier P. Mucin-related epitopes distinguish M cells and enterocytes in rabbit appendix and Peyer's patches. Infect. Immun. 67:1999;357-367.
40. Giannasca P.J., Giannasca K.T., Leichtner A.M., Neutra M.R. Human intestinal M cells display the sialyl Lewis A antigen. Infect. Immun. 67:1999;946-953.
41. Brinck U., Bosbach R., Korabiowska M., Schauer A., Gabius H.-J. Lectin-binding sites in the epithelium of a normal human appendix vermiformis and in acute appendicitis. Histol. Histopathol. 10:1995;61-70.
42. Foster N., Clark M.A., Jepson M.A., Hirst B.H. Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo. Vaccine. 16:1998;536-541.
43. Childers N.K., Denys F.R., McGee N.F., Michalek S.M. Ultrastructural study of liposome uptake by M cells of rat Peyer's patch: An oral vaccine system for delivery of purified antigen. Regul. Immunol. 3:1990;8-16.
44. Chen H., Torchilin V., Langer R. Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13:1996;1378-1383.
45. Gabor F., Wirth M., Jurkovich B., Haberl I., Theyer G., Walcher G., Hamilton G. Lectin-mediated bioadhesion: proteolytic stability and binding-characteristics of wheat germ agglutinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes. J. Control. Release. 49:1997;27-37.
46. Gabor F., Stangl M., Wirth M. Lectin-mediated bioadhesion: binding characteristics of plant lectins on the enterocyte-like cell lines Caco-2, HT-29 and HCT-8. J. Control. Release. 55:1998;131-142.
47. Wirth M., Hamilton G., Gabor F. Lectin-mediated drug targeting: quantification of binding and internalization of wheat germ agglutinin and Solanum tuberosum lectin using Caco-2 and HT-29 cells. J. Drug Target. 6:1998;95-104.
48. Russell-Jones G.J., Veitch H., Arthur L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 190:1999;165-174.
49. Lehr C.-M., Bouwstra J.A., Kok W., Noach A.B.J., de Boer A.G., Junginger H.E. Bioadhesion by means of specific binding of tomato lectin. Pharm. Res. 9:1992;547-553.
50. Wirth M., Fuchs A., Wolf M., Ertl B., Gabor F. Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin-conjugated doxorubicin on Caco-2 cells. Pharm. Res. 15:1998;1031-1037.
51. Kilpatrick D.C., Pusztai A., Grant G., Graham C., Ewen S.W.B. Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS Lett. 185:1985;299-305.
52. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 2. Mechanism of uptake in vitro. Int. J. Pharm. 110:1994;127-136.
53. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 3. Bioadhesion in vivo. Int. J. Pharm. 114:1995;227-236.
54. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 1. Lectin binding to rat small intestine in vitro. Int. J. Pharm. 107:1994;223-230.
55. Carreno-Gomez B., Woodley J.F., Florence A.T. Studies on the uptake of tomato lectin nanoparticles in everted gut sacs. Int. J. Pharm. 183:1999;7-11.
56. Hussain N., Jani P.U., Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14:1997;613-618.
57. Naisbett B., Woodley J. The potential use of tomato lectin for oral drug delivery. 4. Immunological consequences. Int. J. Pharm. 120:1995;247-254.
58. Irache J.M., Durrer C., Duchêne D., Ponchel G. In vitro study of lectin-latex conjugates for specific bioadhesion. J. Control. Release. 31:1994;181-188.
59. Irache J.M., Durrer C., Duchêne D., Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13:1996;1716-1719.
60. Andino R., Silvera D., Suggett S.D., Achacoso P.L., Miller C.J., Baltimore D., Feinberg M.B. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science. 265:1994;1448-1451.
61. Tang S., van Rij R., Silvera D., Andino R. Toward a poliovirus-based simian immunodeficiency virus vaccine: correlation between genetic stability and immunogenicity. J. Virol. 71:1997;7841-7850.
62. Barry E.M., Gomez-Duarte O., Chatfield S., Rappuoli R., Pizza M., Losonsky G., Galen J., Levine M.M. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908. Infect. Immun. 64:1996;4172-4181.
63. Levine M.M., Galen J., Barry E., Noriega F., Tacket C., Sztein M., Chatfield S., Dougan G., Losonsky G., Kotloff K. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors. Behring Inst. Mitt. 98:1997;120-123.
64. Mastroeni P., Bowe F., Cahill R., Simmons C., Dougan G. Vaccines against gut pathogens. Gut. 45:1999;633-635.
65. Sicinski P., Rowinski J., Warchol J.B., Jarzabek Z., Gut W., Szczygiel B., Bielecki K., Koch G. Poliovirus type1 enters the human host through intestinal M cells. Gastroenterology. 98:1990;56-58.
66. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Preferential interaction of Salmonella typhimurium with mouse Peyer's patch M cells. Res. Microbiol. 145:1994;543-552.
67. Jones B.D., Ghori N., Falkow S. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180:1994;15-23.
68. Pascopella L., Raupach B., Ghori N., Monack D., Falkow S., Small P.L.C. Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum. Infect. Immun. 63:1995;4329-4335.
69. Caston A.J., Davis S.S., Williams P. The potential of fimbrial proteins for delaying intestinal transit of oral drug delivery systems. Proc. Control. Release Soc. 17:1990;313-314.
70. Gabor F., Bernkop-Schnürch A., Hamilton G. Bioadhesion to the intestine by means of E. coli K99-fimbriae: Gastrointestinal stability and specificity of adherence. Eur. J. Pharm. Sci. 5:1997;233-242.
71. Isberg R.R., Voorhis D.L., Falkow S. Identification of invasin: A protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell. 50:1987;769-778.
72. Leong J.M., Fournier R.S., Isberg R.R. Identification of the integrin binding domain of the Yersinia pseudotuberculosis invasin protein. EMBO J. 9:1990;1979-1989.
73. Young V.B., Falkow S., Schoolnik G.K. The invasin protein of Yersinia enterocolitica: Internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J. Cell Biol. 116:1992;197-207.
74. Rankin S., Isberg R.R., Leong J.M. The integrin-binding domain of invasin is sufficient to allow bacterial entry into mammalian cells. Infect. Immun. 60:1992;3909-3912.
75. Isberg R.R., van Nhieu G.T. Two mammalian cell internalization strategies used by pathogenic bacteria. Annu. Rev. Genet. 28:1994;395-422.
76. Hussain N., Florence A.T. Utilizing bacterial mechanisms of epithelial cell entry: Invasin-induced oral uptake of latex nanoparticles. Pharm. Res. 15:1998;153-156.
77. Autenrieth I.B., Firsching R. Penetration of M cells and destruction of Peyer's patches by Yersinia enterocolitica: an ultrastructural and histological study. J. Med. Microbiol. 44:1996;285-294.
78. Clark M.A., Hirst B.H., Jepson M.A. M-cell surface β1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect. Immun. 66:1998;1237-1243.
79. Marra A., Isberg R.R. Invasin-dependent and invasin-independent pathways for translocation of Yersinia pseudotuberculosis across the Peyer's patch intestinal epithelium. Infect. Immun. 65:1997;3412-3421.
80. Isberg R.R., Leong J.M. Multiple β1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell. 60:1990;861-871.
81. Beaulieu J.-F. Differential expression of the VLA family of integrins along the crypt-villus axis in the human small intestine. J. Cell Sci. 102:1992;427-436.
82. Bäumler A.J., Tsolis R.M., Heffron F. The lpf fimbrial operon mediates adhesion of Salmonella typhimurium to murine Peyer's patches. Proc. Natl. Acad. Sci. USA. 93:1996;279-283.
83. Wolf J.L., Rubin D.H., Finberg R., Kauffman R.S., Sharpe A.H., Trier J.S., Fields B.N. Intestinal M cells: A pathway for entry of reovirus into the host. Science. 212:1981;471-472.
84. Wolf J.L., Kauffman R.S., Finberg R., Dambrauskas R., Fields B.N., Trier J.S. Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology. 85:1983;291-300.
85. Lee P.W.K., Hayes E.C., Joklik W.K. Protein σ1 is the reovirus cell attachment protein. Virology. 108:1981;156-163.
86. Amerongen H.M., Wilson G.A.R., Fields B.N., Neutra M.R. Proteolytic processing of reovirus is required for adherence to intestinal M cells. J. Virol. 68:1994;8428-8432.
87. Rubas W., Banerjea A.C., Gallati H., Speiser P.P., Joklik W.K. Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capacity to L929 cells in vitro. J. Microencapsul. 7:1990;385-395.
88. Roy M.J., Varvayanis M. Development of dome epithelium in gut-associated lymphoid tissues: Association of IgA with M cells. Cell Tissue Res. 248:1987;645-651.
89. Weltzin R., Lucia-Jandris P., Michetti P., Fields B.N., Kraehenbuhl J.P., Neutra M.R. Binding and transepithelial transport of immunoglobulins by intestinal M cells: Demonstration using monoclonal IgA antibodies against enteric viral proteins. J. Cell Biol. 108:1989;1673-1685.
90. Porta C., James P.S., Phillips A.D., Savidge T.C., Smith M.W., Cremaschi D. Confocal analysis of fluorescent bead uptake by mouse Peyer's patch follicle-associated M cells. Exp. Physiol. 77:1992;929-932.
91. Smith M.W., Thomas N.W., Jenkins P.G., Miller N.G.A., Cremaschi D., Porta C. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp. Physiol. 80:1995;735-743.
92. Zhou F., Kraehenbuhl J.-P., Neutra M.R. Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes. Vaccine. 13:1995;637-644.
93. Pappo J., Ermak T.H., Steger H.J. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology. 73:1991;277-280.
94. Almeida A.J., Alpar H.O. Nasal delivery of vaccines. J. Drug Target. 3:1996;455-467.
95. Tobío M., Gref R., Sánchez A., Langer R., Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15:1998;270-275.
96. Spit B.J., Hendriksen E.G.J., Bruijntjes J.P., Kuper C.F. Nasal lymphoid tissue in the rat. Cell Tissue Res. 255:1989;193-198.
97. Giannasca P.J., Boden J.A., Monath T.P. Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect. Immun. 65:1997;4288-4298.
98. Gebert A. Identification of M-cells in the rabbit tonsil by vimentin immunohistochemistry and in vivo protein transport. Histochem. Cell Biol. 104:1995;211-220.
99. Perry M., Whyte A. Immunology of the tonsils. Immunol. Today. 19:1998;414-421.
100. Gebert A. M-cells in the rabbit tonsil exhibit distinctive glycoconjugates in their apical membranes. J. Histochem. Cytochem. 44:1996;1033-1042.
101. Jeong K.I., Uetsuka K., Nakayama H., Doi K. Glycoconjugate expression in follicle-associated epithelium (FAE) covering the nasal-associated lymphoid tissue (NALT) in specific pathogen-free and conventional rats. Exp. Anim. 48:1999;23-29.
102. Wilson C., Sama A., Clark M.A., Hirst B.H., Wilson J.A. Identification of cell subpopulations in human tonsillar epithelium [abstract]. J. Anat. 192:1998;D13.
103. M.A. Clark, C. Wilson, A. Sama, J.A. Wilson, B.H. Hirst, Differential cytokeratin and glycoconjugate expression by the surface and crypt epithelia of human palatine tonsils. 2000 (submitted for publication).
104. Hietanen J., Salo O.P. Binding of four lectins to normal human oral mucosa. Scand. J. Dent. Res. 92:1984;443-447.
105. Mazumdar S., SenGupta S.K., Param R., Sinha S.N. Binding pattern of eight different lectins in healthy subjects and patients with dysplastic and malignant lesions of the oral cavity. Int. J. Oral Maxillofac. Surg. 22:1993;301-305.
106. Nantwi P.K.K., Cook D.J., Rogers D.J., Smart J.D. Lectins for drug delivery within the oral cavity - Investigation of lectin binding to oral mucosa. J. Drug Target. 5:1997;45-55.
107. Gibbons R.J., Dankers I. Inhibition of lectin-binding to saliva-treated hydroxyapatite, to buccal epithelial cells, and to erythrocytes by salivary components. Am. J. Clin. Nutr. 36:1982;276-283.
108. Watanabe H., Gipson I.K. Detection of blood group differences in human corneal epithelium using a monoclonal antibody and lectins. Arch. Ophthalmol. 112:1994;667-673.
109. Panjwani N., Moulton P., Alroy J., Baum J. Localization of lectin binding sites in human, cat, and rabbit corneas. Invest. Ophthalmol. Vis. Sci. 27:1986;1280-1284.
110. Nicholls T.J., Green K.L., Rogers D.J., Cook J.D., Wolowacz S., Smart J.D. Lectins in ocular drug delivery: an investigation of lectin binding sites on the corneal and conjunctival surfaces. Int. J. Pharm. 138:1996;175-183.
111. Schaeffer H.E., Breitfeller J.M., Krohn D.L. Lectin-mediated attachment of liposomes to cornea: influence on transcorneal drug flux. Invest. Ophthalmol. Vis. Sci. 23:1982;530-533.
112. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.-P., Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:1994;15-23.
113. Kernéis S., Bogdanova A., Kraehenbuhl J.-P., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 277:1997;949-952.
114. Kernéis S., Pringault E. Plasticity of the gastrointestinal epithelium: the M cell paradigm and opportunism of pathogenic microorganisms. Semin. Immunol. 11:1999;205-215.
115. Debard N., Sierro F., Kraehenbuhl J.P. Development of Peyer's patches, follicle-associated epithelium and M cell: lessons from immunodeficient and knockout mice. Semin. Immunol. 11:1999;183-191.
116. Meynell H.M., Thomas N.W., James P.S., Holland J., Taussig M.J., Nicoletti C. Up-regulation of microsphere transport across the follicle-associated epithelium of Peyer's patch by exposure to Streptococcus pneumoniae R36a. FASEB J. 13:1999;611-619.
117. Borghesi C., Taussig M.J., Nicoletti C. Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Lab. Invest. 79:1999;1393-1401.
118. Gebert A., Fassbender S., Werner K., Weissferdt A. The development of M cells in Peyer's patches is restricted to specialized dome-associated crypts. Am. J. Pathol. 154:1999;1573-1582.
119. Batra R.K., Wang-Johanning F., Wagner E., Garver R.I. Jr., Curiel D.T. Receptor-mediated gene delivery employing lectin-binding specificity. Gene Ther. 1:1994;255-260.
120. Khopade A.J., Nandakumar K.S., Jain N.K. Lectin-functionalized multiple emulsions for improved cancer therapy. J. Drug Target. 6:1998;285-292.
121. Russell-Jones G.J., de Aizpurua H.J. Vitamin B12: A novel carrier for orally presented antigens. Proc. Int. Symp. Control. Release Bioact. Mater. 15:1988;85.
122. Marcello A., Loregian A., Cross A., Marsden H., Hirst T.R., Palù G. Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc. Natl. Acad. Sci. USA. 91:1994;8994-8998.
123. Loregian A., Papini E., Satin B., Marsden H., Hirst T.R., Palù G. Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc. Natl. Acad. Sci. USA. 96:1999;5221-5226.